Abstract:Background: Prostate cancer (PCa) is occurred with increasing incidence and heterogeneous pathogenesis. Although clinical strategies are accumulated for PCa prevention, there is still a lack of sensitive biomarkers for the holistic management in PCa occurrence and progression. Based on systems biology and artificial intelligence, translational informatics provides new perspectives for PCa biomarker prioritization and carcinogenic survey. Methods: In this study, gene expression and miRNA-mRNA association data were integrated to construct conditional networks specific to PCa occurrence and progression, respectively. Based on network modeling, hub miRNAs with significantly strong single-line regulatory power were topologically identified and those shared by the condition-specific network systems were chosen as candidate biomarkers for computational validation and functional enrichment analysis. Results: Nine miRNAs, i.e., hsa-miR-1-3p, hsa-miR-125b-5p, hsa-miR-145-5p, hsa-miR-182-5p, hsa-miR-198, hsa-miR-22-3p, hsa-miR-24-3p, hsa-miR-34a-5p , and hsa-miR-499a-5p , were prioritized as key players for PCa management. Most of these miRNAs achieved high AUC values (AUC > 0.70) in differentiating different prostate samples. Among them, seven of the miRNAs have been previously reported as PCa biomarkers, which indicated the performance of the proposed model. The remaining hsa-miR-22-3p and hsa-miR-499a-5p could serve as novel candidates for PCa predicting and monitoring. In particular, key miRNA-mRNA regulations were extracted for pathogenetic understanding. Here hsa-miR-145-5p was selected as the case and hsa-miR-145-5p/NDRG2/AR and hsa-miR-145-5p/KLF5/AR axis were found to be putative mechanisms during PCa evolution. In addition, Wnt signaling, prostate cancer, microRNAs in cancer etc. were significantly enriched by the identified miRNAs-mRNAs, demonstrating the functional role of the identified miRNAs in PCa genesis. Conclusion: Biomarker miRNAs together with the associated miRNA-mRNA relations were computationally identified and analyzed for PCa management and carcinogenic deciphering. Further experimental and clinical validations using low-throughput techniques and human samples are expected for future translational studies.

miRNAs associated with prostate cancer risk and progression

MicroRNAs and Prostate Cancer

MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

MicroRNAs Role in Prostate Cancer

Recent progress in microRNA research for prostate cancer

MicroRNA expression analysis reveals significant biological pathways in human prostate cancer

miRNA as diagnostic and prognostic biomarkers for patients with prostate cancer

Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey

Identification of the Key MicroRNAs and the miRNA-mRNA Regulatory Pathways in Prostate Cancer by Bioinformatics Methods

Using Micrornas As Novel Predictors of Urologic Cancer Survival: an Integrated Analysis.

Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer

Expression of Microrna-99A-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases

Novel Role of Micrornas in Prostate Cancer.

Oncogenic MicroRNAs: Key players in human prostate cancer pathogenesis, a narrative review

Analysis of aberrant miRNA-mRNA interaction networks in prostate cancer to conjecture its molecular mechanisms

Expression profile analysis reveals putative prostate cancer-related microRNAs.

Roles of Micrornas During Prostatic Tumorigenesis and Tumor Progression

A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma.

Identification of Diagnostic and Prognostic Biomarkers for Cancer: Focusing on Genetic Variations in Microrna Regulatory Pathways (Review)

A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer